MBCP - Bone graft substitute

This material is characterised by its excellent biocompatibility and very high osteogenicity.

Its complete resorption and progressive replacement by live, well-structured bone in the short term make it a material of choice for implantologists.

Long term success of bone increase and the osseointegration of the material play a decisive role when it comes to choosing the bone regeneration material which will allow long term stabilisation of the implant.

Safety '100% Synthetic substitute'

• A calcium phosphate-base composition which corresponds chemically to natural bone
• There is no risk of pathogen transmission related to the product.

Bone Substitution that is ‘Progressive and Complete’

• Biphasic ceramic - 60% Hydroxyapatite (HA) and 40 % β Tricalcium phosphate (β-TCP)
• A Micro and Macroporous architecture which allows guided bone colonisation in the core of the biomaterial, proven in 6 months

Bioactive: Osteoconductive and osteogenic

• Complete interconnected porosity 70%
• 2/3 macropores (300 to 600 µ)
• 1/3 micropores (< 10 µ)

Easy to use

• Adapted range: granules of different diameters packaged in syringes or vials
• Ready for use, sterile, expiration in 5 years

Proven:Over 400,000 Implants

• A safe, synthetic (neither animal nor human origin) product.
• Clinical retrospection substantiated by over 500 international publications
• An industrial process that is mastered
• Competitive prices

Indications:

• Periodontal bone fillings
• Alveolar ridge augmentation
• Filling of peri-implant defects
• Sinus lifting
• Filling of cyst cavities
• Possible increase in the bone volume of an autograft